1.
The Efficacy of FLAG Protocol in Treatment of Refractory and Relaps Acute Myelogenous Leukemia
FLAG方案治疗难治/复发急性髓性白血病的疗效观察
2.
Comparison of Regimens in Treatment of Refractory and Relapsed Acute Myeloid Leukemia;
难治/复发性急性髓系白血病治疗方案比较
3.
Priming Regimen for Patients with Refractory or Relapsed Acute Myelogenous Leukemia (in Vivo and in Vitro);
预激方案治疗急性难治性、复发性髓性白血病的初步研究（体内、体外）
4.
Clinical Investigation of G-CSF Priming Regiment in Treatment of Relapsing, Refractory and Senile Acute Myeloid Leukemia;
预激方案治疗难治复发性及老年性急性髓系白血病的临床研究
5.
Clinical Observation of FLAG Regimen in Treatment of Refractory or Relapsed Acute Myelogenous Leukemia
FLAG方案治疗难治性复发性急性髓细胞白血病的临床观察
6.
Clinical Analysis of FLAG Regimen in the Treatment of Relapsed/refractory Acute Myeloid Leukemia;
FLAG方案治疗复发/难治急性髓系白血病的临床病例分析
7.
Effects of FLAG Regimen in Treatment Refractory and Relapsed Acute Myeloid Leukemia;
FLAG方案治疗难治复发急性髓系白血病的疗效观察
8.
Treating Four Refractory and Relapse Acute Myelocytic Leukemia Patients with Sequential Dual Induction Chemotherapy: FA Combined with Priming Chemotherapy
FA+CAG序贯双诱导治疗复发难治急性髓系白血病4例
9.
Clinical study of preexcitation program containing Amsacrine in the treatment of refractory or relapsed Acute Myeloid Leukemia
含安丫啶的预激方案治疗难治/复发急性髓细胞白血病的临床研究
10.
IDA-FLAG Regimen in Treatment of Patients with Refractory or Relapsed Acute Leukemia
IDA-FLAG方案治疗复发难治的急性白血病
11.
Treatment outcome of FLAG regimen for the refractory and relapsed acute leukemia
FLAG方案治疗难治复发性急性白血病的临床观察
12.
The Experimental Research and Clinical Observation on the Treatment of Refractory/relapse Acute Myeloid Leukemia with Topoisomerase Ⅰ Inhibitors Topotecan;
拓扑异构酶Ⅰ抑制剂拓扑替康治疗难治/复发性急性髓系白血病的基础与临床研究
13.
Clinical Study on Fludarabin Combined with Cytarabine Regimen in the Treatment of Patients with Refractory and Relapsed Acute Myeloid Leukemia
氟达拉滨联合阿糖胞苷方案治疗复发及难治性急性髓系白血病的临床研究
14.
Efficacy of aclacinomycin plus intermediate dose of cytarabine for patients with refractory and relapsed acute myeloid leukemia
阿柔比星联合中剂量阿糖胞苷诱导治疗难治和复发性急性髓样白血病的疗效
15.
Clinical Study on Regimen Cyclophosphamide,Ara-C and Topotecan (CAT) in Treatment of Patients with Refractoryor Relapsed Acute Myelogenous Leukemia
环磷酰胺、阿糖胞苷和拓扑替康联合方案治疗难治和复发急性髓系白血病的临床研究
16.
Study of Gene Expression Profiles in Refractory Acute Myeloid Leukemia (M2a);
难治性急性髓系白血病（M2a）基因表达谱的研究
17.
Clinical Research of Modified CAG Regimen for the Treatment of Relapsed Acute Myeloid Leukemia
改良CAG方案治疗成人复发性急性髓系白血病的临床研究
18.
Aclacinomycin and Ara-c on acute refractory and recurrent leukemia
阿克拉霉素与阿糖胞苷联合方案治疗难治及复发性急性白血病